findmyKOL
Clinical trialNCT03787732CompletedPhase 4Interventional

Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation

SponsorVanderbilt University Medical CenterEnrollment1,067Acute Respiratory FailureHypotension on InductionIntubation Complication
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Complications are common during tracheal intubation of critically ill patients. Nearly one in five patients undergoing intubation in the intensive care unit experiences cardiovascular collapse, defined as severe hypotension, vasopressor administration, cardiac arrest or death. Cardiovascular collapse during intubation is associated with increased resource utilization and decreased survival. Administration of 500 mL of intravenous crystalloid solution beginning prior to induction may prevent cardiovascular collapse. The only prior trial examining fluid bolus administration during intubation found no effect on cardiovascular collapse or clinical outcomes overall, but a hypothesis-generating subgroup analysis suggested potential benefit to fluid bolus administration among patients receiving positive pressure ventilation between induction and laryngoscopy. Therefore, we propose a randomized trial comparing fluid bolus administration versus none with regard to cardiovascular collapse among critically adults undergoing intubation with positive pressure ventilation between induction and laryngoscopy.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • David R Janz, MD, MSCI

    Louisiana State University Health Sciences Center in New Orleans

    Principal Investigator
  • Derek W Russell, MD

    University of Alabama at Birmingham

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • Louisiana State University School of Medicine

    New Orleans, Louisiana, United States

  • Ochsner Medical Center | Ochsner Health System

    New Orleans, Louisiana, United States

  • Lahey Hospital & Medical Center

    Burlington, Massachusetts, United States

  • Hennepin County Medical Center

    Minneapolis, Minnesota, United States

  • University of Mississippi Medical Center

    Jackson, Mississippi, United States

  • Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina, United States

  • Oregon Health & Science University

    Portland, Oregon, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • Baylor Scott & White Medical Center - Temple

    Temple, Texas, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fluid Bolus
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Feb 2019
Primary completion
24 May 2021
Completion
21 Jun 2021
Last update posted
12 Aug 2021
Registered enrollment
1,067
Registry id
NCT03787732

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.